We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
Cap. Flow
-$328M
Cap. Flow %
-6.34%
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$121M
2
PTCT icon
PTC Therapeutics
PTCT
+$81.6M
3
VTRS icon
Viatris
VTRS
+$76.4M
4
TGT icon
Target
TGT
+$69.6M
5
FIVE icon
Five Below
FIVE
+$60.3M

Top Sells

Rank Stock Value
1
ASO icon
Academy Sports + Outdoors
ASO
+$66.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$62.3M
3
ULTA icon
Ulta Beauty
ULTA
+$62.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$59.8M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 45.3%
2 Consumer Staples 9.22%
3 Consumer Discretionary 6.86%
4 Technology 3.5%
5 Communication Services 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLPX
76
DELISTED
Olaplex Holdings
OLPX
$9.94M 0.19%
+636,000
New +$12.1M
AMD icon
77
Advanced Micro Devices
AMD
$799B
$8.97M 0.17%
+82,000
New +$9.79M
DDOG icon
78
Datadog
DDOG
$81.6B
$8.48M 0.16%
56,000
-35,000
-38% -$5.12M
AMYT
79
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$8.27M 0.16%
1,000,000
+200,000
+25% +$1.8M
AHCO icon
80
AdaptHealth
AHCO
$806M
$8.02M 0.16%
500,000
-636,000
-56% -$11.4M
PPC icon
81
Pilgrim's Pride
PPC
$6.56B
$7.53M 0.15%
+300,000
New +$7.79M
SNOW icon
82
Snowflake
SNOW
$110B
$7.33M 0.14%
32,000
-29,500
-48% -$7.63M
HYPD
83
Hyperion DeFi Inc
HYPD
$40.5M
$7M 0.14%
+28,708
New +$7.13M
IMCR icon
84
Immunocore
IMCR
$1.75B
$5.38M 0.1%
+180,000
New +$4.54M
EDSA icon
85
Edesa Biotech
EDSA
$48.6M
$4.33M 0.08%
+208,084
New +$5.76M
ASMB icon
86
Assembly Biosciences
ASMB
$524M
$4.12M 0.08%
166,667
– –
ADIL
87
Adial Pharmaceuticals
ADIL
$10.5M
$3.65M 0.07%
+2,908
New +$3.98M
MARK
88
DELISTED
Remark Holdings, Inc.
MARK
$3.47M 0.07%
423,729
– –
PHXM
89
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$3.4M 0.07%
194,408
-79,349
-29% -$1.5M
ADXN
90
Addex Therapeutics
ADXN
$7.34M
$2.89M 0.06%
28,404
-2,358
-8% -$258K
TPR icon
91
Tapestry
TPR
$32.7B
$2.88M 0.06%
+77,594
New +$2.97M
USAU icon
92
US Gold Corp
USAU
$248M
$2.86M 0.06%
+408,627
New +$3.07M
VSTM icon
93
Verastem
VSTM
$519M
$2.82M 0.05%
166,667
– –
SIEN
94
DELISTED
Sientra, Inc.
SIEN
$2.66M 0.05%
120,000
-15,600
-12% -$427K
AYTU icon
95
AYTU BioPharma
AYTU
$25M
$2.57M 0.05%
+118,997
New +$2.96M
CBUS icon
96
Cibus
CBUS
$143M
$2.38M 0.05%
+45,664
New +$3.41M
TELA icon
97
TELA Bio
TELA
$38.5M
$2.23M 0.04%
192,000
-156,000
-45% -$1.89M
PIXY
98
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$2.22M 0.04%
79
– –
PTE
99
DELISTED
PolarityTE, Inc. Common Stock
PTE
$2.07M 0.04%
+338,474
New +$3.92M
BCTXW
100
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.95M 0.04%
375,000
– –
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.

  • Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
  • Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
  • Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
  • Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
  • Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
  • Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.